Maurice Reimann

3.1k citations
14 papers · 563 indexed · 1 hit paper · h-index 10

Maurice Reimann

14 papers receiving 559 citations

Hit Papers

Cellular senescence: Neither irreversible nor reversible4920242026202510203040

Peers

Maurice Reimann
Comparison fields: 5 of 71
  • Oncology 206
  • Aging 12
  • Immunology 126
  • Physiology 146
  • Molecular Biology 385
Replace T. V. Kalinichenko with:
T. V. Kalinichenko United States
Serguei R. Romanov United States
Paul Biggs United Kingdom
Nelson R. Salgado United States
Zelda Lichtensztejn Canada
Calvina Kek Singapore
Corrado Caslini United States
Alysia R. Bryll United States
Vaidehi Krishnan Singapore
Yukio Tonozuka Japan
Maurice Reimann relative to T. V. Kalinichenko United States T. V. Kalinichenko's profile →
Citations per field
00.5×10×15×
T. V. Kalinichenko · 1×
Citations per year

Countries citing papers authored by Maurice Reimann

Since Specialization
Citations

This map shows the geographic impact of Maurice Reimann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurice Reimann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurice Reimann more than expected).

Fields of papers citing papers by Maurice Reimann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurice Reimann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurice Reimann. The network helps show where Maurice Reimann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maurice Reimann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maurice Reimann Line = papers co-authored together Maurice Reimann links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1
Cellular senescence: Neither irreversible nor reversiblebreakdown →
202449
2 202021
3 20169
4 20151
5 201362
6 201116
7 201172
8 20113
9 20111
10 2010150
11 200767
12 200333
13 200263
14 199816

About Maurice Reimann

Maurice Reimann is a scholar working on Aging, Cancer Research and Oncology, having authored 14 papers that have together received 563 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (4 papers), Epigenetics and DNA Methylation (3 papers), Lymphoma Diagnosis and Treatment (3 papers), NF-κB Signaling Pathways (3 papers), Acute Myeloid Leukemia Research (2 papers), DNA Repair Mechanisms (2 papers), Immune cells in cancer (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). The work is most often cited by research in Oncology (206 citations), Aging (12 citations) and Immunology (126 citations). Maurice Reimann has collaborated with scholars based in Germany, Austria and Australia. Frequent co-authors include Clemens A. Schmitt, Soyoung Lee, Bernd Dörken, Christoph Loddenkemper, Harald Stein, Jan R. Dörr, Peter Aichele, Vedrana Tabor, Wolfgang Deppert and Ella Kim. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026